Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Medicines & Healthy Lifestyle

Premenstrual Mood Swings A ‘Key Public Health Issue’: Study

admin by admin
September 7, 2022
in Medicines & Healthy Lifestyle


omen all over the world are affected by premenstrual symptoms, but just how prevalent are they? Researchers say mood symptoms are so common that they are a “key public health issue globally.”

Premenstrual symptoms vary widely, from physical symptoms such as fatigue and bloating to mood swings and anxiety. About 80% of women report having at least one physical or mood symptom, the researchers wrote in a study published in the Archives of Women’s Health.

“However, there is limited data on the occurrence of premenstrual symptoms across nations and by different age groups,” they wrote.

To shed further light on this important matter, researchers looked at a “large international dataset” comprising survey responses of 238,114 Flo app users from 140 countries. The participants, who ranged in age from 18 to 55, were asked about their premenstrual symptoms and if they experience them “every menstrual cycle, some cycles, or never.”

Of the symptoms, food craving was the most commonly reported one, with 85.28% of women experiencing it. This was followed by mood swings or anxiety, experienced by 64.18% of participants, and fatigue (57.3%).

“In the current sample, many of the symptoms that increased with age are associated with perimenopause, such as hot flashes, absentmindedness, and low libido,” the researchers wrote. “Thus, it makes sense that these premenstrual symptoms increased with age, potentially as women were approaching menopause, given that the sample included women up to age 55.”

However, mood swings and anxiety symptoms “did not differ significantly” between the age groups. In fact, contrary to previous studies that suggested mood swings would lessen with age, particularly among women 45 and above, the team found the symptoms were “a common, persistent complaint across age ranges.”

With a majority of participants (61-64%) reporting it every menstrual cycle, this suggests that “premenstrual mood symptoms are a key public health issue globally,” the researchers said.

“Our study demonstrates that premenstrual mood symptoms are incredibly common worldwide,” study senior author Jennifer Payne, of the University of Virginia (UVA) School of Medicine, said in a news release. “More important, a majority of women reported that their premenstrual symptoms interfered with their everyday life at least some of the time.”

Indeed, periods can impact women’s day-to-day lives. When New Zealand announced its decision to distribute free sanitary products in schools last year, Prime Minister Jacinda Ardern recalled how one in 12 young people had to skip school because they did not have access to period products like tampons, pads or medicines for menstrual cramps.

With the results of the study, researchers are expecting healthcare providers to be more aware of just how prevalent these symptoms are, hopefully getting women the help they need.

In the future, studies could also look into why there is such a wide disparity in premenstrual symptoms between countries, with some reporting more of them and others less. For instance, the mood and anxiety symptoms were as high as 64% in Egypt, Jordan, Brazil, Lebanon and Brazil, but as low as 28% in places like Mali, Cameroon and Congo. According to researchers, similar variations were found in other studies as well.

“Understanding whether differences in biology or culture underlie the country level rates will be an important future research direction,” Payne said.





Source link

Tags: healthissuekeymoodpremenstrualpublicstudyswings
Previous Post

Date With Adult Model Leads to Testicular Cancer Diagnosis

Next Post

Investigational CRISPR Therapy Gets Orphan Drug Status for Hereditary Angioedema

Next Post

Investigational CRISPR Therapy Gets Orphan Drug Status for Hereditary Angioedema

Recommended

Behavioral Therapy Tied to Reduced Tic Severity in Youth With Tourette Syndrome

August 21, 2022

Bioweapon Labs Must Be Shut Down and Scientists Prosecuted

January 17, 2023

Don't miss it

Pharmaceutical

Mr. President, health care has a data problem

February 8, 2023
Medicines & Healthy Lifestyle

Amazon’s Virtual Health Clinic Raises Patient Privacy Issues

February 8, 2023
Medicines & Healthy Lifestyle

Know The Health Benefits Of Irish Sea Moss

February 8, 2023
News

Sharp Cutoff at Age 70

February 8, 2023
Pharmaceutical

Medical Bulletin 8/February/2023

February 8, 2023
Pharmaceutical

Biden to call for expanding caps on insulin prices

February 7, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.